Mayo Clinic to use blockchain for clinical trial

Rochester, Minn.-based Mayo Clinic will use blockchain technology from Triall in an upcoming clinical trial studying pulmonary hypertension, the tech company said Sept. 1.

The technology will be used for data capture, document management, study monitoring and e-consent. Triall said its blockchain-registered audit trails can bolster data integrity.

"It is wonderful to work with some of the thought leaders within Mayo Clinic, and we are confident our collaboration will pave the way towards further innovation and enhanced quality in clinical development, utilizing the strengths of blockchain technology where these truly add value," stated Hadil Es-Sbai, co-founder and CEO of Triall.

The two-year pulmonary arterial hypertension trial will include 10 research sites and more than 500 patients across the country, according to the news release.

Next Article

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.

© 2023 Netspective Media LLC. All Rights Reserved.

Built on Oct 3, 2023 at 1:31pm